Gossamer Bio/$GOSS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Gossamer Bio
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Ticker
$GOSS
Sector
Primary listing
Employees
162
Headquarters
Website
Gossamer Bio Metrics
BasicAdvanced
$49m
-
-$0.78
2.15
-
Price and volume
Market cap
$49m
Beta
2.15
52-week high
$3.87
52-week low
$0.16
Average daily volume
8.9m
Financial strength
Current ratio
2.204
Quick ratio
1.921
Long term debt to equity
-125.076
Total debt to equity
-125.668
Interest coverage (TTM)
-15.58%
Profitability
EBITDA (TTM)
-171.286
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-324.82%
Operating margin (TTM)
-308.46%
Effective tax rate (TTM)
0.05%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
-52.29%
Return on equity (TTM)
215.10%
Valuation
Price to revenue (TTM)
0.871
Price to book
-0.31
Price to tangible book (TTM)
-0.31
Price to free cash flow (TTM)
-0.284
Free cash flow yield (TTM)
-351.93%
Free cash flow per share (TTM)
-0.739
Growth
Revenue change (TTM)
-55.42%
Earnings per share change (TTM)
246.19%
3-year earnings per share growth (CAGR)
-31.84%
What the Analysts think about Gossamer Bio
Analyst ratings (Buy, Hold, Sell) for Gossamer Bio stock.
Gossamer Bio Financial Performance
Revenues and expenses
Gossamer Bio Earnings Performance
Company profitability
Gossamer Bio News
AllArticlesVideos
GOSS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
Newsfile Corp·23 hours ago
GOSSAMER DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOSS
Newsfile Corp·1 day ago
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOSS
Newsfile Corp·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs